In contrast to the flamboyant, high-living Messier, the self-styled J2M, his likely successor Jean-Rene Fourtou, is an experienced industrial technocrat, currently vice-chairman of Aventis, the decidedly European Franco-German pharmaceuticals group. Foutou, 63, is said to be close to Claude Bebear, the honorary chairman of Axa, the insurance group that has been lobbying for top-level changes at Vivendi.